J
Jing Li
Researcher at University of Texas MD Anderson Cancer Center
Publications - 165
Citations - 7030
Jing Li is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Radiosurgery & Medicine. The author has an hindex of 35, co-authored 142 publications receiving 5022 citations. Previous affiliations of Jing Li include University of Texas Health Science Center at Houston & Ocean University of China.
Papers
More filters
Journal ArticleDOI
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial
Anita Mahajan,Salmaan Ahmed,Mary Frances McAleer,Jeffrey S. Weinberg,Jing Li,Paul D. Brown,Stephen H. Settle,Sujit S. Prabhu,Frederick F. Lang,Nicholas B. Levine,Susan L. McGovern,Erik P. Sulman,Ian E. McCutcheon,Syed Azeem,Daniel P. Cahill,Claudio E. Tatsui,Amy B. Heimberger,Sherise D. Ferguson,Amol J. Ghia,Franco DeMonte,Shaan M. Raza,Nandita Guha-Thakurta,James Chih-Hsin Yang,Raymond Sawaya,Kenneth R. Hess,Ganesh Rao +25 more
TL;DR: SRS of the surgical cavity in patients who have had complete resection of one, two, or three brain metastases significantly lowers local recurrence compared with that noted for observation alone, suggesting the use of SRS after brain metastasis resection could be an alternative to whole-brain radiotherapy.
Journal ArticleDOI
Whole-brain radiotherapy in the management of brain metastasis.
TL;DR: The standard treatment approach of whole-brain radiotherapy is presented and new directions are discussed, including the role of chemical modifiers and the management and prevention of neurocognitive deficits.
Journal ArticleDOI
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
Paul D. Brown,Vinai Gondi,Stephanie L. Pugh,Wolfgang A. Tomé,Jeffrey S. Wefel,Terri Armstrong,Joseph Bovi,Cliff G. Robinson,Andre Konski,Deepak Khuntia,David R. Grosshans,Tammie L.S. Benzinger,Deborah Watkins Bruner,Mark R. Gilbert,David Roberge,Vijayananda Kundapur,Kiran Devisetty,Sunjay Shah,Kenneth Y. Usuki,Bethany Anderson,Baldassarre Stea,Harold Yoon,Jing Li,Nadia N. Laack,Tim J. Kruser,Steven J. Chmura,Wenyin Shi,Snehal Deshmukh,Minesh P. Mehta,Lisa A. Kachnic +29 more
TL;DR: HA-WBRT plus memantine better preserves cognitive function and patient-reported symptoms, with no difference in intracranial PFS and OS, and should be considered a standard of care for patients with good performance status who plan to receive WBRT for brain metastases with no metastases in the HA region.
Journal ArticleDOI
Awake craniotomy to maximize glioma resection: methods and technical nuances over a 27-year period
Shawn L. Hervey-Jumper,Jing Li,Darryl Lau,Annette M. Molinaro,David W. Perry,Lingzhong Meng,Mitchel S. Berger +6 more
TL;DR: It is concluded that awake brain tumor surgery can be safely performed with extremely low complication and failure rates regardless of ASA classification; body mass index; smoking status; psychiatric or emotional history; seizure frequency and duration; and tumor site, size, and pathology.
Journal ArticleDOI
Regression After Whole-Brain Radiation Therapy for Brain Metastases Correlates With Survival and Improved Neurocognitive Function
TL;DR: WBRT-induced tumor shrinkage correlates with better survival and NCF preservation, thus making enhancement of radiation response a worthwhile aim in this patient population.